Condition

Neuroendocrine Neoplasms clinical trials and research

• 6Clinical trials
• 13Countries

Newest Neuroendocrine Neoplasms clinical trials

All recruiting trials (6)

• Surufatinib for adults with advanced neuroendocrine neoplasms in routine care

  This study will see if daily oral surufatinib, given alone or with other treatments, helps adults with advanced neuroendocrine tumors when used in regular clinical practice.

  Recruiting at 4 sites Phase 4 Shanghai Zhongshan Hospital · Shanghai and 3 other locations · NCT07272512

• Collection of blood samples from patients with neuroendocrine neoplasms

  This study is collecting blood samples from patients with neuroendocrine neoplasms to see if they can find new markers that help understand the disease better and improve future treatments.

  Recruiting University Hospital, Antwerp · Rumst, Antwerp and 7 other locations · NCT06541080

• Testing how a new medicine is absorbed by tumors in patients with advanced lung and neuroendocrine cancers

  This study is testing a new medicine to see how well it gets absorbed by tumors in adults with advanced lung or neuroendocrine cancers who haven't had success with other treatments.

  Recruiting Phase 1 Boehringer Ingelheim · Amsterdam · NCT05963867

• Testing different doses of BI 764532 for small cell lung cancer and neuroendocrine cancers

  This study is testing different doses of a new cancer drug called BI 764532 to see if it can help adults with advanced small cell lung cancer and other neuroendocrine tumors that haven't responded to other treatments.

  Recruiting at 37 sites Phase 2 Boehringer Ingelheim · Mobile, Alabama and 58 other locations · NCT05882058

• Combining Lutathera and Olaparib for Inoperable Neuroendocrine Tumors

  This study is testing if combining Lutathera and Olaparib can safely shrink tumors in adults with inoperable gastroenteropancreatic neuroendocrine tumors.

  Recruiting Phase 1/2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT04086485

• Treatment for inoperable pheochromocytoma and paraganglioma using Lu-177-DOTATATE

  This study is testing if a new treatment called Lu-177-DOTATATE can help people with inoperable pheochromocytoma and paraganglioma by delaying the return of their tumors.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT03206060

Related topics

Quick answers

How many Neuroendocrine Neoplasms clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 13 countries. The most sites are in United States (3 trials), Belgium (2 trials), China (2 trials), Netherlands (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 1, Phase 1/2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →